Surgical Management of High-Risk Upper Tract Urothelial Carcinoma

2014 ◽  
pp. 131-152
Author(s):  
Georgios Gakis ◽  
Ashish M. Kamat ◽  
Vitaly Margulis ◽  
Seth P. Lerner ◽  
Arnulf Stenzl
2021 ◽  
Author(s):  
Georges Abi Tayeh ◽  
Nour Khalil ◽  
Marwan Alkassis ◽  
Fouad Aoun ◽  
Chady Waked ◽  
...  

The COVID-19 pandemic has modified the management of urothelial carcinoma (UC). Eighteen months after the onset of the pandemic, a scoping narrative review was able to state that radical cystectomy for UC should not be delayed beyond 10 weeks when neoadjuvant chemotherapy (NAC) was administered and 12 weeks when it was not. NAC should be considered when imminent chemotherapy cannot be performed. Early cystectomy should not be delayed when indicated for patients with high-risk non-MIBC. Patients with non-MIBC should still receive their induction doses of intravesical instillations. Diagnostic cystoscopy should not be deferred in symptomatic patients. Surgical management of upper tract urothelial carcinoma (UTUC) allows for a wider deferral interval.


2021 ◽  
Vol 79 ◽  
pp. S1105-S1106
Author(s):  
A. Martini ◽  
C. Lonati ◽  
A. Necchi ◽  
A. Briganti ◽  
F. Montorsi ◽  
...  

2019 ◽  
Vol 37 (4) ◽  
pp. 292.e1-292.e9 ◽  
Author(s):  
Firas G. Petros ◽  
Wei Qiao ◽  
Nirmish Singla ◽  
Timothy N. Clinton ◽  
Haley Robyak ◽  
...  

BJUI Compass ◽  
2021 ◽  
Author(s):  
Omar Alhalabi ◽  
Matthew T. Campbell ◽  
Lianchun Xiao ◽  
Ana C. Adriazola ◽  
Nathaniel R. Wilson ◽  
...  

2011 ◽  
Vol 185 (4S) ◽  
Author(s):  
Joseph Pugh ◽  
Aaron Grossman ◽  
Sijo Parekattil ◽  
Li-Ming Su

2020 ◽  
Vol 203 (6) ◽  
pp. 1101-1108 ◽  
Author(s):  
Beat Foerster ◽  
Mohammad Abufaraj ◽  
Firas Petros ◽  
Mounsif Azizi ◽  
Mohit Gupta ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document